Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions. [PDF]
Fijolek J, Sniady A.
europepmc +1 more source
Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation. [PDF]
Juto A +8 more
europepmc +1 more source
Renal-Limited Presentation of Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody Vasculitis: A Case Report. [PDF]
Lurie A +3 more
europepmc +1 more source
Concomitant Histological Features of Membranous Nephropathy and Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis. [PDF]
Rajesh C +9 more
europepmc +1 more source
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook. [PDF]
Chen SF, Li ZY, Zhao MH, Chen M.
europepmc +1 more source
A Case of Pulmonary Hemorrhage, Supratherapeutic International Normalized Ratio (INR), and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Unmasking a Potential Link to Tirzepatide. [PDF]
Shakour H +3 more
europepmc +1 more source
Liver biopsy revealing anti-neutrophil cytoplasmic antibody-associated vasculitis: a tale for a challenging diagnosis. [PDF]
Lahbacha B +8 more
europepmc +1 more source
Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians. [PDF]
Massicotte-Azarniouch D +12 more
europepmc +1 more source
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. [PDF]
Gagne SJ +27 more
europepmc +1 more source
Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis. [PDF]
Liu W +10 more
europepmc +1 more source

